Real-world analysis of community colorectal neoplasia screening based on stool DNA methylation detection

Real-world analysis of community colorectal neoplasia screening based on stool DNA methylation detection

This study aimed to assess the effectiveness of stool DNA methylation detection (sDNAMD) in improving colorectal neoplasia (CN) detection rates and colonoscopy compliance in a real-world community setting. Between July 1, 2023, and June 30, 2024, residents aged 50–75 from Maqiao Town, Minhang Distri...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ming-sheng Fu, Shu-xian Pan, Xun-quan Cai, Ya-wen Cao, Li-yuan Jin, Qin-cong Pan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Oncology
Subjects:	colorectal neoplasia stool DNA methylation detection fecal occult blood testing screening colorectal cancer
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1562698/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic efficacy of fecal-based miR-92a for advanced colorectal neoplasia: a prospective multicenter screening trial
by: Jia-Chen Wang, et al.
Published: (2025-06-01)

Fecal occult blood testing in colorectal cancer screening programs
by: N. V. Severskaya, et al.
Published: (2022-09-01)

The Cost‐Effectiveness of a Multi‐Target Stool DNA‐Based Screening (COLOTECT), FIT, Colonoscopy and No Screening for Colorectal Cancer
by: Junjie Huang, et al.
Published: (2025-04-01)

The effect on colorectal cancer incidence and staging with population-based FOBT-screening in Sweden
by: Hanna Ribbing Wilén, et al.
Published: (2025-04-01)

Significance of Fusobacterium nucleatum Combined with SFRP2 and SDC2 Gene Methylation Detection in Early Screening of Colorectal Cancer
by: ZHONG FANGCHAO, et al.
Published: (2025-06-01)

Predictors of stages of adoption of colorectal cancer screening among adults attending primary healthcare centers in Turkey
by: Elif Dönmez, et al.
Published: (2025-03-01)

Bioinformatic screen with clinical validation for the identification of novel stool based mRNA biomarkers for the detection of colorectal lesions including advanced adenoma
by: Houcong Liu, et al.
Published: (2025-08-01)

Evaluating the implementation of colorectal cancer screening practices at King Abdul-Aziz Medical City, Riyadh
by: Maram S. Al Turki, et al.
Published: (2025-04-01)

Assessing the impact of a single qualitative fecal immunochemical test on colonoscopy prioritization and mortality in risk-stratified patients with suspected colorectal cancer: a retrospective cohort studyResearch in context
by: Felipe F. Quezada-Diaz, et al.
Published: (2025-10-01)

Circulating DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer
by: Beibei Chen, et al.
Published: (2025-04-01)

Adherence to Follow-Up Colonoscopy After a Positive Stool-Based Test in Patients Aged 45–49 Years: Real-World Differences Between Multitarget Stool DNA Testing and Fecal Immunochemical or Fecal Occult Blood Testing
by: Mallik Greene, et al.
Published: (2025-01-01)

Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial
by: Carrie M. Nielson, et al.
Published: (2018-09-01)

Modern approaches to early diagnosis of CRC
by: E. V. Kiseleva, et al.
Published: (2023-04-01)

Cost effectiveness analysis of three colorectal cancer screening modalities in Kuwait
by: Amrizal Muhammad Nur, et al.
Published: (2025-03-01)

Donor-centric administration of the stool donor program is vital to its feasibility and patient safety
by: Amanda J. Kabage, et al.
Published: (2025-12-01)

Analysis of SDC2 and SEPT9 promoters methylation in plasma cfDNA to detect colorectal and precancerous lesions
by: Viktoria Borobova, et al.
Published: (2025-05-01)

Stool and blood biomarkers for colorectal cancer management: an update on screening and disease monitoring
by: Alessandro Mannucci, et al.
Published: (2024-11-01)

Clinical indications for host-cell DNA methylation markers in cervical screening and management of cervical intraepithelial neoplasia: A review
by: S. Dick, et al.
Published: (2025-06-01)

Factors Influencing the Choice Between Multi-Target Stool DNA and Colonoscopy for Colorectal Cancer Screening Among Alaska Native Peoples
by: Lauren A. Jeffries, et al.
Published: (2025-01-01)

Methylation-based smoking signatures in blood and tissue samples for the prediction of self-reported smoking status and mortality in patients with colorectal cancer
by: Tanwei Yuan, et al.
Published: (2025-07-01)

The Role of Microbiota and Early Detection in Colorectal Cancer Through Fecal Screening
by: Muhammad Iqbal
Published: (2024-02-01)

Proportion and characteristics of screen-detected and non-screen-detected colorectal cancers in Germany
by: Michel Hornschuch, et al.
Published: (2024-11-01)

Fecal methylated syndecan-2 (SDC2) testing for early screening of colorectal cancerous and precancerous lesions: A real-world retrospective study in China
by: Boyu Qin, et al.
Published: (2025-01-01)

Proteasome inhibition induces DNA methylation alteration by attenuating the synthesis of DNA methyltransferase 1 and 3B in colorectal cancer
by: Wenwen Zhou, et al.
Published: (2025-03-01)

Serum DNA methylome of the colorectal cancer serrated pathway enables non‐invasive detection
by: María Gallardo‐Gómez, et al.
Published: (2024-11-01)

Genome-wide DNA methylation profiles of colorectal tumors in Lynch syndrome and familial adenomatous polyposis
by: Satu Mäki-Nevala, et al.
Published: (2025-08-01)

Noninvasive diagnostics for colorectal cancer: molecular genetic fecal DNA analysis
by: G. M. Butrovich, et al.
Published: (2014-09-01)

Analysis of LINE-1 DNA Methylation in Colorectal Cancer, Precancerous Lesions, and Adjacent Normal Mucosa
by: Inga Kildusiene, et al.
Published: (2025-07-01)

Risk prediction of advanced colorectal neoplasia among diabetic patients: A derivation and validation study
by: Martin CS Wong, et al.
Published: (2024-05-01)

Diagnostic accuracy evaluation of individual or combinational fecal immunochemical test, M3 gene, KRAS mutation and tumor methylation burden in colorectal carcinoma
by: Junyue Xu, et al.
Published: (2025-07-01)

The Impact of Age on Preferences for Colorectal Cancer Surveillance Strategies: Are Fecal Immunochemical Tests FIT for Surveillance?
by: Maddison Dix, et al.
Published: (2025-03-01)

The impact of redesigned advance notification letters on intention to screen for bowel cancer: a randomised controlled experiment
by: Katelyn E. Collins, et al.
Published: (2025-06-01)

The impact of increasing multitarget stool DNA use among colorectal cancer screeners in a self-insured US employer population
by: Joanne M Hathway, et al.
Published: (2021-01-01)

Colorectal Cancer Screening Based on Fecal Immunochemical Test and Risk Assessment: A Population-based Study Including Two Million Participants in China
by: Dong Hang, et al.
Published: (2025-06-01)

Anatomical Distribution of Polyps Is Different for Men and Women With Positive Stool Tests
by: Joseph C. Anderson, et al.
Published: (2025-02-01)

The effect of 1,25(OH)2D3 on Dickkopf-1 methylation in colorectal cancer
by: Hongyan Sun, et al.
Published: (2025-03-01)

Assessing hard and loose “endpoints”: comparison of patient and expert Bristol Stool Scale scoring of 2280 fecal samples [version 2; peer review: 2 approved]
by: Jørgen Valeur, et al.
Published: (2024-12-01)

<i>CYP24A1</i> DNA Methylation in Colorectal Cancer as Potential Prognostic and Predictive Markers
by: Ru-Hua Zhou, et al.
Published: (2025-01-01)

The advantages of the immunochemical test in detecting hidden blood in the stool
by: S. V. Vasiliev, et al.
Published: (2015-12-01)

The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review
by: Faris Shweikeh, et al.
Published: (2024-01-01)